{"id":148,"date":"2018-12-06T00:29:26","date_gmt":"2018-12-06T00:29:26","guid":{"rendered":"http:\/\/soignant.reseau-amylose.org\/?page_id=148"},"modified":"2022-06-29T11:38:10","modified_gmt":"2022-06-29T09:38:10","slug":"evenements-du-reseau-amylose","status":"publish","type":"page","link":"http:\/\/reseau-amylose.org\/jesuissoignant\/documentation\/evenements-du-reseau-amylose\/","title":{"rendered":"JFMA : Journ\u00e9e Francophone Multidisciplinaire de l’Amylose"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
La JFMA : Journ\u00e9e Francophone Multidisciplinaire de l’Amylose est une journ\u00e9e pour \u00e9changer sur les nouveaut\u00e9s scientifiques, cliniques et th\u00e9rapeutiques et l’occasion privil\u00e9gi\u00e9e d\u2019\u00e9change et de discussion entre des experts et tous les acteurs des sp\u00e9cialit\u00e9s m\u00e9dicales et biologiques confront\u00e9es au diagnostic et \u00e0 la prise en charge des patients. <\/span><\/h6>
Visionnez les replays des journ\u00e9es amylose disponibles sur le site internet du R\u00e9seau www\/reseau-amylose.org ou sur notre chaine Youtube – CLIQUEZ ICI<\/a><\/span><\/h6>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
9e<\/sup>\u00a0JOURN\u00c9E FRANCOPHONE MULTIDISCIPLINAIRE DE\u00a0L\u2019AMYLOSE<\/h5>

DU DIAGNOSTIC AU PRONOSTIC ET \u00c0 LA TH\u00c9RAPEUTIQUE<\/h3>

Pour consulter ou\u00a0t\u00e9l\u00e9charger les\u00a0pr\u00e9sentations, veuillez cliquer sur\u00a0les\u00a0noms des\u00a0orateurs mentionn\u00e9es en\u00a0couleur\u00a0bleue.<\/p>

Ouverture de\u00a0la\u00a0rencontre par\u00a0la\u00a0Comit\u00e9 Scientifique et\u00a0l\u2019Association Fran\u00e7aise contre l\u2019Amylose<\/h5>
Session 1\u00a0– Regards crois\u00e9s neufs\u202f: de\u00a0la\u00a0souris aux\u00a0g\u00e8nes et\u00a0hormones<\/h5>

Mod\u00e9rateurs\u202f:
Vincent\u00a0AUDARD<\/span><\/em>, Cr\u00e9teil
Beno\u00eet\u00a0FUNALOT<\/span><\/em>, Cr\u00e9teil<\/p>

Un\u00a0nouveau mod\u00e8le de\u00a0souris amylo\u00efde
Christophe\u00a0SIRAC<\/span><\/em>, Limoges – REPLAY<\/a>
Discussion<\/strong>
Les\u00a0g\u00e8nes\u202f: activit\u00e9s d\u2019un\u00a0centre de\u00a0r\u00e9f\u00e9rence
Silvia OGHINA<\/span>, Cr\u00e9teil<\/strong><\/em><\/a> – REPLAY<\/a>
Discussion<\/strong>
Amylose et\u00a0hormones\u202f: cas\u00a0clinique
Magali\u00a0COLOMBAT<\/span>, Toulouse<\/strong><\/em><\/a> REPLAY<\/a>
Discussion<\/strong><\/p>

Session 2\u00a0– Atteinte t\u00e9gumentaires, valvulaires et\u00a0cardiaque<\/h5>

Mod\u00e9rateurs\u202f:
Jean-Christophe EICHER<\/span><\/em>, Dijon
Magali\u00a0COLOMBAT<\/span><\/em>, Toulouse<\/p>

Amylose et infiltration t\u00e9gumentaire\u202f: du poignet \u00e0 l’\u00e9paule Marc-Antoine DELBARRE<\/span>, Lille<\/strong><\/em><\/a> – REPLAY<\/a>
Discussion<\/strong>
Amylose et\u00a0valve aortique\u202f: liaison dangereuse\u202f?
Olivier\u00a0LAIREZ<\/span>, Toulouse<\/strong><\/em><\/a> – REPLAY<\/a>
Discussion<\/strong>
Preuve anatomopathologique pour la\u00a0diagnostic d\u2019amylose\u00a0AL<\/span>\u00a0ou\u00a0ATTRw<\/span>t avec\u00a0MGUS<\/span>\u202f: jusqu\u2019o\u00f9 aller\u202f?
Benjamin\u00a0FERRAND<\/span>, Dijon<\/strong><\/em><\/a> – REPLAY<\/a>
Discussion<\/strong>
Pr\u00e9valence et\u00a0type des\u00a0embolies dans les\u00a0amyloses cardiaques
Thibaut\u00a0WAJCHERT<\/span>, Versailles<\/strong><\/em><\/a> – REPLAY<\/a>
Discussion<\/strong><\/p>

Session 3\u00a0– Amylose\u202f: cas\u00a0clinique saison 1<\/h5>

Mod\u00e9rateurs\u202f:
Magali\u00a0COLOMBAT<\/span><\/em>, Toulouse
Arnaud\u00a0JACCARD<\/span><\/em>, Limoges
Sophie\u00a0VALLEIX<\/span><\/em>, Paris<\/p>

Cas\u00a0clinique Amylose\u00a0ALECT<\/span>2
Anissa\u00a0MOKTEFI<\/span>, Cr\u00e9teil<\/strong><\/em><\/a> – REPLAY<\/a>
Cas\u00a0clinique\u202f: Amylose Apo\u00a0A1
Silvia\u00a0OGHINA<\/span>, Cr\u00e9teil<\/strong><\/em><\/a> – REPLAY<\/a>
Cas\u00a0clinique\u202f: Amylose Apo\u00a0A1
Lucie\u00a0BICHON-<\/span>TREULET<\/span><\/em>, Reims – REPLAY<\/a>
Discussion<\/strong><\/p>

Session 4\u00a0– Bien \u00e9valuer le\u00a0pronostic des\u00a0amyloses pour adapter la\u00a0prise en\u00a0charge<\/h5>

Mod\u00e9rateurs\u202f:
Frank\u00a0BRIDOUX<\/span><\/em>, Poitiers
Michel\u00a0SLAMA<\/span><\/em>, Paris<\/p>

Qualit\u00e9 de\u00a0vie\u00a0et\u00a0amylose\u202f: une\u00a0\u00e9chelle d\u00e9di\u00e9e pour mesurer la\u00a0qualit\u00e9 de\u00a0vie\u00a0et\u00a0le\u00a0pronostic
Mounira\u00a0KHAROUBI<\/span>, Cr\u00e9teil<\/strong><\/em><\/a> – REPLAY<\/a>
Discussion<\/strong>
Amyloses h\u00e9r\u00e9ditaires\u00a0ATTR<\/span>v et\u00a0pronostic r\u00e9nal
Julien\u00a0DANG<\/span>, Cr\u00e9teil<\/strong><\/em><\/a> – REPLAY<\/a>
Discussion<\/strong>
Amylose\u00a0AL<\/span>\u202f: l\u2019atteinte h\u00e9patique est-elle un marqueur pronostic\u202f?
Vincent\u00a0LEROY<\/span><\/em>, Cr\u00e9teil
Discussion<\/strong>
Nouveaux marqueurs dans les\u00a0amyloses cardiaques
Martin\u00a0NICOL<\/span>, Paris<\/strong><\/em><\/a> – REPLAY<\/a>
Discussion<\/strong><\/p>

Session 5\u00a0– Amylose\u00a0\u2013 cas\u00a0clinique saison 2<\/h5>

Mod\u00e9rateurs\u202f:
Vincent\u00a0AUDARD<\/span><\/em>, Cr\u00e9teil
Magali\u00a0COLOMBAT<\/span><\/em>, Toulouse<\/p>

Cas\u00a0clinique\u202f: ApoA4\u00a0r\u00e9nale
Anne\u00a0MOREAU<\/span>, Toulouse<\/strong><\/em><\/a> – REPLAY<\/a>
Cas\u00a0clinique\u202f: une\u00a0nouvelle amylose h\u00e9r\u00e9ditaire
Sophie\u00a0VALLEIX<\/span><\/em>, Paris
Cas\u00a0clinique\u202f: amylose\u00a0AL<\/span>
Ornella\u00a0RIZZO<\/span>, Limoges<\/strong><\/em><\/a> – REPLAY<\/a>
Discussion<\/strong><\/p>

Conf\u00e9rence\u00a0\u2013\u00a0CRISPER<\/span> 19\u202f: une\u00a0nouvelle voie th\u00e9rapeutique dans les\u00a0amyloses – REPLAY<\/a><\/h5>

Mod\u00e9rateurs\u202f:
Thibaud\u00a0DAMY<\/span><\/em>, Cr\u00e9teil
Arnaud\u00a0JACCARD<\/span><\/em>, Limoges
Julian\u00a0GILLMORE<\/span><\/em>, Londres<\/p>

Discussion<\/strong><\/p>

Session 6\u00a0– Actualit\u00e9s dans l\u2019amylose\u00a0AA<\/span><\/h5>

Mod\u00e9rateurs\u202f:
Frank\u00a0BRIDOUX<\/span><\/em>, Poitiers
Marc-Antoine DELBARRE<\/span><\/em>, Lille<\/p>

AA<\/span>\u202f: Quoi de\u00a0neuf\u202f?
Sophie\u00a0GEORGIN-<\/span>LAVIALLE<\/span>, Paris<\/strong><\/em><\/a> – REPLAY<\/a>
AA<\/span>\u202f: cas\u00a0cliniques interactifs
Sophie\u00a0GEORGIN-<\/span>LAVIALLE<\/span>, Paris<\/strong><\/em><\/a>
Discussion<\/strong><\/p>

Session 7\u00a0– Actualit\u00e9s dans le\u00a0traitement des\u00a0amyloses\u00a0AL<\/span>\u00a0et\u00a0ATTR<\/span><\/h5>

Mod\u00e9rateurs\u202f:
Bertrand\u00a0ARNULF<\/span><\/em>, Paris
Olivier\u00a0DECAUX<\/span><\/em>, Rennes
Martin\u00a0NICOL<\/span><\/em>, Paris<\/p>

Immunoth\u00e9rapie et\u00a0amylose\u00a0AL<\/span>
Michelle\u00a0PIROTTE<\/span>, Li\u00e8ge<\/strong><\/em><\/a> – REPLAY<\/a>
Discussion<\/strong>
Actualit\u00e9s sur\u00a0le\u00a0V\u00e9netoclax
Romain\u00a0GOUNOT<\/span>, Cr\u00e9teil<\/strong><\/em><\/a> – REPLAY<\/a>
Discussion<\/strong>
Greffe d\u2019organe et amylose AL<\/span>\u202f: actualit\u00e9s du\u00a0registre fran\u00e7ais
Thierry\u00a0ANTOINE<\/span><\/em>, Poitiers
Discussion<\/strong>
Stabilisateur de\u00a0le\u00a0transthyr\u00e9tine et\u00a0amylose\u00a0ATTR<\/span>\u00a0(ATTR<\/span>v et\u00a0ATTRw<\/span>t)
Thibaud\u00a0DAMY<\/span>, Cr\u00e9teil<\/strong><\/em><\/a> – REPLAY<\/a>
Discussion<\/strong>
Tafamidis et\u00a0scintigraphie osseuse
Shirley\u00a0ODOUARD<\/span>, Cr\u00e9teil<\/strong><\/em><\/a> – REPLAY<\/a>
Discussion<\/strong>
Greffe h\u00e9patique et\u00a0stabilisateur de\u00a0la\u00a0transthyr\u00e9tinedans les\u00a0amyloses\u00a0ATTR<\/span>v
Vincent\u00a0ALGALARRONDO<\/span><\/em>, Paris
Discussion<\/strong>
Antisens et\u00a0amylose\u00a0ATTR<\/span>
Michel\u00a0SLAMA<\/span>, Paris<\/strong><\/em><\/a> – REPLAY<\/a>
Discussion<\/strong><\/p>

Conclusion\u00a0\u2013 cl\u00f4ture de\u00a0la\u00a0journ\u00e9e<\/h5>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
8e<\/sup> JOURN\u00c9E FRANCOPHONE MULTIDISCIPLINAIRE DE L\u2019AMYLOSE<\/h5>

LES AMYLOSES : UNE VISION PARTAG\u00c9E<\/h3>

Pour consulter ou\u00a0t\u00e9l\u00e9charger les\u00a0pr\u00e9sentations, veuillez cliquer sur\u00a0les\u00a0titres mentionn\u00e9es en\u00a0bleu.<\/p>

Introduction<\/h5>

Ouverture de\u00a0la\u00a0rencontre par\u00a0le\u00a0comit\u00e9 scientifique et\u00a0l\u2019Association Fran\u00e7aise contre l\u2019Amylose
Introduction\u00a0AFCA<\/span><\/strong><\/a><\/p>

Session 1<\/h5>

Amylose\u202f: regards crois\u00e9s<\/strong><\/p>

Mod\u00e9rateurs\u202f:<\/strong>\u00a0Pr\u00a0Bertrand Arnulf (Paris), Pr\u00a0Arnaud Jaccard (Limoges), Pr\u00a0Sophie Georgin Lavialle (Paris)<\/p>

Introduction
Pr\u00a0Thibaud Damy (Cr\u00e9teil)<\/p>

Intelligence artificielle et\u00a0scintigraphie osseuse
Dr<\/sup>\u00a0Marc Antoine Delbarre (Amiens)<\/strong><\/a> – REPLAY<\/a><\/p>

Atteintes cardiaques et\u00a0extra cardiaques dans les\u00a0amyloses cardiaques
Mounira Kharoubi (Cr\u00e9teil)<\/strong><\/a> – REPLAY<\/a>
Discussion<\/p>

Sudoscan dans l\u2019amylose\u00a0TTR<\/span>\u00a0s\u00e9nile
Mounira Kharoubi (Cr\u00e9teil) – REPLAY<\/a><\/p>

Sudoscan dans l\u2019amylose\u00a0AA – <\/span>Dr<\/sup> Samuel Deshayes (C\u00e6n) – REPLAY<\/a>
Discussion<\/p>

NGS<\/span> des amyloses\u202f: les r\u00e9sultats – Pr Sophie Valleix (Paris)<\/strong><\/a> – REPLAY<\/a><\/p>

Les\u00a0amyloses h\u00e9r\u00e9ditaires non\u00a0TTR<\/span> vues par le n\u00e9phrologue – Pr\u00a0Vincent Audard (Cr\u00e9teil)<\/strong><\/a>
Discussion<\/p>

Session 2 : De\u00a02010\u00a0\u00e0 2020\u202f: 10\u00a0ann\u00e9es o\u00f9 l\u2019amylose a\u00a0transform\u00e9 nos\u00a0pratiques<\/strong><\/h5>

Mod\u00e9rateurs\u202f:<\/strong>\u00a0Dr<\/sup>\u00a0Estelle Desport (Poitiers), Pr\u00a0Olivier Decaux (Rennes), Pr\u00a0Olivier Lairez (Toulouse)<\/p>

La vision de l\u2019interniste – Pr Eric Hachulla (Lille) – REPLAY<\/a><\/p>

La vision de l\u2019h\u00e9matologue – Pr Arnaud Jaccard (Limoges) – REPLAY<\/a><\/p>

La vision du g\u00e9n\u00e9ticien –\u00a0Pr\u00a0Benoit Funalot (Cr\u00e9teil)<\/strong><\/a> – REPLAY<\/a><\/p>

La vision de l\u2019anatomopathologiste – Dr<\/sup> Magali Colombat (Toulouse) – REPLAY<\/a><\/p>

La vision du cardiologue –\u00a0Dr<\/sup>\u00a0Soulef Guendouz (Cr\u00e9teil)<\/strong><\/a> – REPLAY<\/a><\/p>

La vision du neurologue –\u00a0Dr<\/sup>\u00a0Thierry Gendre (Cr\u00e9teil)<\/strong><\/a> – REPLAY<\/a><\/p>

La vision du n\u00e9phrologue – Pr Frank Bridoux (Poitiers) – REPLAY<\/a>
Discussion<\/p>

Table ronde<\/h5>

Les\u00a0RCP<\/span>\u00a0des\u00a0amyloses pour une\u00a0meilleure prise en\u00a0charge<\/strong><\/p>

Mod\u00e9rateurs\u202f:<\/strong>\u00a0Pr\u00a0Frank Bridoux (Poitiers), Dr<\/sup>\u00a0Magali Colombat (Toulouse), Pr\u00a0Thibaud Damy (Cr\u00e9teil)<\/p>

L\u2019exp\u00e9rience de la fili\u00e8re\u00a0MARIH – <\/span>Pr\u00a0Arnaud Jaccard, David Lavergne (Limoges)<\/p>

L\u2019exp\u00e9rience du NNERF – <\/span>Pr\u00a0Michel Slama (Paris)<\/p>

L\u2019exp\u00e9rience de la\u00a0FAI<\/span>2R –\u00a0Pr\u00a0Sophie Georgin Lavialle (Paris)<\/strong><\/a><\/p>

Le lancement de la fili\u00e8re Cardiogen – Pr\u00a0Philippe Charron (Paris)
Discussion<\/p>

Session 3<\/h5>

Actualit\u00e9s dans le\u00a0traitement des\u00a0amyloses\u00a0AL<\/span>\u00a0et\u00a0AA<\/span><\/strong><\/p>

Mod\u00e9rateurs\u202f:<\/strong>\u00a0Pr\u00a0Bertrand Arnulf (Paris), Dr<\/sup>\u00a0Murielle Roussel (Toulouse), Dr<\/sup>\u00a0Karim Belhadj Merzoug (Cr\u00e9teil)<\/p>

Chimioth\u00e9rapie et\u00a0amylose\u00a0AL<\/span>\u00a0 – Pr\u00a0Olivier Decaux (Rennes)<\/p>

Immunoth\u00e9rapie et\u00a0amylose\u00a0AL<\/span>\u00a0 – Pr\u00a0Arnaud Jaccard (Limoges)<\/p>

Prise en\u00a0charge de\u00a0l\u2019amylose\u00a0AA<\/span> chez le patient dialys\u00e9 ou gr\u00e9ff\u00e9 –\u00a0Pr\u00a0H\u00e9l\u00e8ne Fran\u00e7ois Pradier (Paris)<\/strong><\/a>
Discussion<\/p>

Session 4<\/h5>

Actualit\u00e9s dans le\u00a0traitement des\u00a0amyloses \u00e0 transthyr\u00e9tine<\/strong><\/p>

Mod\u00e9rateurs\u202f:<\/strong>\u00a0Dr<\/sup>\u00a0Jocelyn Inamo (Fort de\u00a0France), Pr\u00a0Dania Mohty (Limoges), Dr<\/sup>\u00a0Antoine Jobbe Duval (Bron)<\/p>

Traitement des formes neurologiques – Pr\u00a0Violaine Plant\u00e9 Bordeneuve (Cr\u00e9teil)<\/p>

Tafamidis dans les formes cardiaques – Pr Thibaud Damy (Cr\u00e9teil)<\/strong><\/a><\/p>

Les nouveaux essais antisens et les oligonucl\u00e9otides dans les formes neurologiques – Pr\u00a0Michel Slama (Paris)<\/p>

L\u2019immunoth\u00e9rapie anti-TTR – Pr\u00a0Olivier Lairez (Toulouse)
Discussion<\/p>

Conclusion \u2013 Cl\u00f4ture du congr\u00e8s<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
7e<\/sup>\u00a0JOURN\u00c9E FRANCOPHONE MULTIDISCIPLINAIRE DE\u00a0L\u2019AMYLOSE<\/h5>

Pour t\u00e9l\u00e9charger les\u00a0pr\u00e9sentations, veuillez cliquer sur\u00a0les\u00a0titres mentionn\u00e9s en\u00a0couleur\u00a0bleue.<\/p>

Introduction<\/h5>

Ouverture de\u00a0la\u00a0journ\u00e9e par\u00a0le\u00a0comit\u00e9 scientifique<\/p>

Pr\u00e9sentation de\u00a0l\u2019Association Fran\u00e7aise contre l\u2019Amylose<\/strong>
Pr\u00a0Thibaud Damy (Cr\u00e9teil)
Voir la\u00a0pr\u00e9sentation<\/strong><\/a><\/p>

Conf\u00e9rence internationale<\/h5>

Pr\u00a0Per\u00a0Westermark<\/strong><\/a>\u00a0(Su\u00e8de), \u00e9diteur en\u00a0chef du\u00a0Journal Amyloid<\/p>

Session 1<\/h5>

Nouveaux outils diagnostiques dans les\u00a0amyloses cardiaques<\/strong><\/p>

Nouveaux outils diagnostiques dans les\u00a0amyloses cardiaques
Mod\u00e9rateurs\u202f:<\/strong>\u00a0Pr\u00a0Thibaud Damy (Cr\u00e9teil), Dr<\/sup>\u00a0Silvia Oghia (Cr\u00e9teil), Pr\u00a0Michel Slama (Paris)<\/p>

Score Diagnostic dans l\u2019amylose cardiaque<\/strong>\u00a0(12\u202fmin)<\/em>
Dr<\/sup>\u00a0Eve\u00a0Cariou<\/strong><\/a>
Discussion\u202f: 5\u202fmin<\/em><\/p>

TEP<\/span>\u00a0Scanner ou\u00a0IRM<\/span>\u00a0dans les\u00a0amyloses\u00a0TTR<\/span><\/strong>\u00a0(12\u202fmin)<\/em>
Pr\u00a0Pierre\u2011Yves Marie<\/strong><\/a>(Nancy)
Discussion\u202f: 5\u202fmin<\/em><\/p>

Evaluer l\u2019insuffisance chronotrope dans les\u00a0amyloses\u00a0TTR<\/span><\/strong>\u00a0(12\u202fmin)<\/em>
Dr<\/sup>\u00a0Astrid Monfort\u2011Brafine<\/strong><\/a>(Fort\u2011de\u2011France)
Discussion\u202f: 5\u202fmin<\/em><\/p>

Session 2<\/h5>

Amyloses\u00a0AA<\/span>\u00a0et\u00a0AL<\/span>\u202f: nouveaux outils, nouvelles pistes<\/strong><\/p>

Mod\u00e9rateurs\u202f:<\/strong>
Pr\u00a0David Buob (Paris), Dr<\/sup>\u00a0Jocelyn Inamo (Fort\u2011de\u2011France), Dr<\/sup>\u00a0Fabien Le\u00a0Bras (Cr\u00e9teil)<\/p>

Microbiote dans l\u2019amylose\u00a0AA<\/span><\/strong>\u00a0(12\u202fmin)<\/em>
Dr<\/sup>\u00a0Samuel Deshayes<\/strong><\/a>(C\u00e6n)
Discussion\u202f: 5\u202fmin<\/em><\/p>

RNA<\/span>\u2011seq\u00a0dans les\u00a0MRGS<\/span>\u00a0et\u00a0les\u00a0amyloses\u00a0AL<\/span><\/strong>(12\u202fmin)<\/em>
Dr<\/sup>\u00a0Christophe Sirac<\/strong><\/a>\u00a0(Limoges)
Discussion\u202f: 5\u202fmin<\/em><\/p>

D\u00e9terminer le\u00a0r\u00e9arrangement de\u00a0la\u00a0cha\u00eene l\u00e9g\u00e8re par\u00a0spectrom\u00e9trie<\/strong>\u00a0(12\u202fmin)<\/em>
Dr<\/sup>\u00a0Magali Colombat<\/strong><\/a>(Toulouse)
Discussion\u202f: 5\u202fmin<\/em><\/p>

Rechercher les\u00a0atteintes extra\u2011r\u00e9nales dans la\u00a0maladie de\u00a0Randall<\/strong>(12\u202fmin)<\/em>
Dr<\/sup>\u00a0Florent Joly<\/strong><\/a>(Poitiers)
Discussion\u202f: 5\u202fmin<\/em><\/p>

Session 3<\/h5>

Flash cas\u00a0cliniques<\/strong><\/p>

Mod\u00e9rateurs<\/strong>\u00a0:
Dr<\/sup>\u00a0Vincent Algalarrondo (Paris), Dr<\/sup>\u00a0Diane Bodez (Cr\u00e9teil), Pr\u00a0Sophie Valleix (Paris)<\/p>

Cas\u00a0clinique 1\u00a0(7\u202fmin)<\/strong>
Rouge Congo positif\u202f: est\u2011ce\u00a0vraiment une\u00a0amylose\u202f?
Dr<\/sup>\u00a0Magali Colombat<\/strong><\/a>(Toulouse)<\/p>

Cas\u00a0clinique 2\u00a0(7\u202fmin)<\/strong>
Nouvelle mutation alg\u00e9rienne
Dr<\/sup>\u00a0Magali Colombat (Toulouse), Dr<\/sup>\u00a0Christian Delamarche (Rennes), Dr<\/sup>\u00a0Silvia Oghina (Paris)<\/strong><\/a><\/p>

Cas\u00a0clinique 3\u00a0(7\u202fmin)<\/strong>
Une\u00a0prise en\u00a0charge multidisciplinaire
Dr<\/sup>\u00a0Ludivine Eliahou (Paris)<\/strong><\/a><\/p>

Session 4<\/h5>

Devenir des\u00a0amyloses, mieux comprendres les\u00a0causes de\u00a0d\u00e9c\u00e8s pour mieux les\u00a0pr\u00e9venir<\/strong><\/p>

Mod\u00e9rateurs\u202f:<\/strong>
Pr\u00a0Vincent Audard (Cr\u00e9teil), Pr\u00a0Gilles Grateau (Paris), Dr<\/sup>\u00a0Antoine Huart (Toulouse)<\/p>

Mode de\u00a0d\u00e9c\u00e8s des\u00a0amyloses cardiaques<\/strong>\u00a0(12\u202fmin)<\/em>
Mounira Kharoubi<\/strong><\/a>(Cr\u00e9teil)
Discussion\u202f: 5\u202fmin<\/p>

Mode de\u00a0d\u00e9c\u00e8s des\u00a0amyloses \u00e0 transthyr\u00e9tine greff\u00e9 du\u00a0foie<\/strong>\u00a0(12\u202fmin)<\/em>
Dr<\/sup>\u00a0Vincent Algalarrondo<\/strong><\/a>\u00a0(Paris) Discussion\u202f: 5\u202fmin<\/p>

Les\u00a0amyloses\u00a0AA<\/span><\/strong>\u00a0(12\u202fmin)<\/em>
Dr<\/sup>\u00a0Alexandre Terre<\/strong><\/a>\u00a0(Paris)
Discussion\u202f: 5\u202fmin<\/p>

Session 5<\/h5>

Du\u00a0nouveau dans le\u00a0traitement de\u00a0l\u2019amylose\u00a0AL<\/span><\/strong><\/p>

Mod\u00e9rateurs\u202f:<\/strong>
Dr<\/sup>\u00a0Laurent Frenzel (Paris), Pr\u00a0Arnaud Jaccard (Limoges), Pr\u00a0Damien Logeart (Paris)<\/p>

Vision d\u2019ensemble et\u00a0perspectives, nouvelles\u00a0guidelines.<\/strong>
Dexam\u00e9thasone dans l\u2019amylose\u00a0AL<\/span>\u202f: quel b\u00e9n\u00e9fice sur\u00a0le\u00a0clone lymphocytaire\u202f?<\/strong>\u00a0(20\u202fmin)<\/em>
Pr\u00a0Arnaud Jaccard<\/strong><\/a>(Limoges)
Discussion\u202f: 4\u202fmin<\/em><\/p>

Le\u00a0Daratumumab\u202f: quoi de\u00a0neuf\u202f?<\/strong>\u00a0(12\u202fmin)<\/em>
Dr<\/sup>\u00a0Antoine Huart<\/strong><\/a>(Toulouse)
Discussion\u202f: 4\u202fmin<\/em><\/p>

Peut\u2011on\u00a0tenir compte de\u00a0la\u00a0cytog\u00e9n\u00e9tique pour traiter les\u00a0amyloses\u00a0AL<\/span>\u202f?<\/strong>\u00a0(12\u202fmin)<\/em>
Dr<\/sup>\u00a0Fabien Le\u00a0Bras<\/strong><\/a>(Cr\u00e9teil)
Discussion\u202f: 4\u202fmin<\/em><\/p>

Dexam\u00e9thasone\u202f: quels risques dans les\u00a0amyloses cardiaques s\u00e9v\u00e8res\u202f?<\/strong>\u00a0(12\u202fmin)<\/em>
M\u00e9lanie B\u00e9zard<\/strong><\/a>(Paris)
Discussion\u202f: 4\u202fmin<\/em><\/p>

Membrane de\u00a0haute perm\u00e9abilit\u00e9 dans les\u00a0gammapathies\u202f: pour quel patient\u202f?<\/strong>\u00a0(12\u202fmin)<\/em>
Dr<\/sup>\u00a0Simo Belmouaz<\/strong><\/a>(Poitiers)
Discussion\u202f: 4\u202fmin<\/em><\/p>

Session 6<\/h5>

Du\u00a0nouveau dans le\u00a0traitement des\u00a0amyloses \u00e0 transthyr\u00e9tine\u202f?<\/strong><\/p>

Mod\u00e9rateurs<\/strong>\u00a0:
Pr\u00a0Dania Mohty (Limoges), Pr\u00a0Olivier Lairez (Toulouse), Pr\u00a0Violaine Plant\u00e9-Bordeneuve (Cr\u00e9teil)<\/p>

Essai\u00a0ATTRACT<\/span>\u202f: am\u00e9lioration de\u00a0la\u00a0survie dans les\u00a0amyloses cardiaques\u00e0 transthyr\u00e9tine h\u00e9r\u00e9ditaire ou\u00a0s\u00e9nile<\/strong>\u00a0(12\u202fmin)
Dr<\/sup>\u00a0Diane Bodez<\/strong><\/a>(Cr\u00e9teil)
Discussion\u202f: 5\u202fmin<\/p>

Essais\u00a0APPOLO<\/span>\u00a0et\u00a0IONIS<\/span>\u202f: quel impact sur\u00a0les\u00a0\u00e9v\u00e9nements cardiaques et\u00a0les\u00a0marqueurs cardiaques des\u00a0amyloses h\u00e9r\u00e9ditaires neurologiques \u00e0 transthyr\u00e9tine<\/strong>\u00a0(12\u202fmin)
Pr\u00a0Michel Slama<\/strong><\/a>(Paris)
Discussion\u202f: 5\u202fmin<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
6e<\/sup>\u00a0JOURN\u00c9E FRANCOPHONE MULTIDISCIPLINAIRE DE\u00a0L\u2019AMYLOSE<\/h5>

Pour consulter ou\u00a0t\u00e9l\u00e9charger les\u00a0pr\u00e9sentations, veuillez cliquer sur\u00a0les\u00a0titres mentionn\u00e9es en\u00a0bleu.<\/p>

Introduction<\/h5>

Le\u00a0comit\u00e9 scientifique et\u00a0l\u2019Association Fran\u00e7aise contre l\u2019Amylose<\/p>

Projets de\u00a0l\u2019Association Fran\u00e7aise contre l\u2019Amylose<\/h5>

Voir les\u00a0projets<\/strong><\/a>
Yves Ghiron, pr\u00e9sident, Fran\u00e7oise Pelcot, administrateur<\/p>

Conf\u00e9rence\u202f: g\u00e9n\u00e9tique et\u00a0amylose<\/h5>

Le\u00a0s\u00e9quen\u00e7age haut\u2011d\u00e9bit dans l\u2019amylose, pour qui\u00a0et\u00a0quand\u202f?<\/p>

Mod\u00e9rateurs\u202f: Pr\u00a0Beno\u00eet Funalot (Paris), Pr\u00a0Sophie Georgin\u2011Lavialle (Paris)
Intervenante\u202f: Pr\u00a0Sophie Valleix (Paris)<\/p>

Session 1\u00a0– Les\u00a0questions br\u00fblantes<\/h5>

Mod\u00e9rateurs\u202f: Pr\u00a0Vincent Audard (Cr\u00e9teil), Dr<\/sup>\u00a0Jocelyn Inamo (Fort\u2011de\u2011France)<\/p>

09. 50<\/strong>
Les\u00a0infections sont\u2011elles encore responsables d\u2019amylose\u00a0AA<\/span>\u00a0en\u00a02018\u202f? (15\u202fmin)
Intervenante\u202f: Pr\u00a0Sophie Georgin\u2011Lavialle (Paris)
Discussion\u202f: 5\u202fmin<\/p>

10. 10<\/strong>
Gammapathie et\u00a0amylose\u00a0TTR<\/span>\u202f: jusqu\u2019o\u00f9 aller\u202f?<\/strong><\/a>
Intervenant\u202f: Dr<\/sup>\u00a0Olivier Lairez (Toulouse)
Discussion\u202f: 5\u202fmin<\/p>

Session 2\u00a0– Outils diagnostics\u202f: pour qui\u00a0et\u00a0comment interpr\u00e9ter\u202f?<\/h5>

Mod\u00e9rateurs\u202f: Dr<\/sup>\u00a0Diane Bodez (Cr\u00e9teil), Pr\u00a0Arnaud Jaccard (Limoges)<\/p>

10. 30<\/strong>
De\u00a0l\u2019anatomopathologie \u00e0 la\u00a0spectrom\u00e9trie de\u00a0masse<\/strong><\/a>
Intervenante\u202f: Dr<\/sup>\u00a0Magali Colombat (Toulouse)
Discussion\u202f: 5\u202fmin<\/p>

10. 50<\/strong>
Scintigraphie osseuse et\u00a0fixations extracardiaques\u202f?<\/strong><\/a>
Intervenant\u202f: Dr<\/sup>\u00a0Nathan Malka (Paris)
Discussion\u202f: 5\u202fmin<\/p>

Session 3\u00a0– Evaluation des\u00a0amyloses\u202f: de\u00a0nouveaux outils \u00e0 ne\u00a0pas\u00a0n\u00e9gliger\u202f!<\/h5>

Mod\u00e9rateurs\u202f: Dr<\/sup>\u00a0Olivier Lairez (Toulouse), Pr\u00a0Michel Slama (Clamart)<\/p>

11. 40<\/strong>
Scintigraphie\u00a0DMSA<\/span>, un\u00a0nouvel outil dans l\u2019\u00e9valuation r\u00e9nale des\u00a0amyloses\u202f?<\/strong><\/a>
Intervenant\u202f: Pr\u00a0Vincent Audard (Cr\u00e9teil)
Discussion\u202f: 5\u202fmin<\/p>

12. 00<\/strong>
Epreuve d\u2019effort coupl\u00e9e \u00e0 la\u00a0mesure de\u00a0la\u00a0consommation en\u00a0oxyg\u00e8ne<\/strong><\/a>
Intervenant\u202f: Dr<\/sup>\u00a0Martin Nicol (Paris)
Discussion\u202f: 5\u202fmin<\/p>

12. 20<\/strong>
Sudoscan et\u00a0neuropathie dans les\u00a0amyloses\u00a0TTR<\/span>\u00a0(15\u202fmin)
Intervenant\u202f: Pr\u00a0Jean\u2011Pascal Lefaucheur (Cr\u00e9teil)
Discussion\u202f: 5\u202fmin<\/p>

Session 4\u00a0– Nouveaux visages des\u00a0amyloses au\u00a0sein des\u00a0disciplines m\u00e9dicales<\/h5>

Mod\u00e9rateurs\u202f: Pr\u00a0Olivier Decaux (Rennes), Pr\u00a0Gilles Grateau (Paris)<\/p>

13. 50<\/strong>
L\u2019amylose vue\u00a0par\u00a0les\u00a0g\u00e9n\u00e9ralistes<\/strong><\/a>
Intervenant\u202f: Dr<\/sup>\u00a0S\u00e9bastian Marciano (Paris)
Discussion\u202f: 5\u202fmin<\/p>

14. 10<\/strong>
Les\u00a0amyloses vues par\u00a0les\u00a0ORL<\/span><\/strong><\/a>
Intervenante\u202f: Dr<\/sup>\u00a0Sophie Bartier (Paris)
Discussion\u202f: 5\u202fmin<\/p>

14. 30<\/strong>
Le\u00a0suivi des\u00a0gammapathies, le\u00a0point de\u00a0vue\u00a0de\u00a0l\u2019h\u00e9matologue<\/strong><\/a>
Intervenant\u202f: Pr\u00a0Olivier Decaux (Rennes)
Discussion\u202f: 5\u202fmin<\/p>

14. 50<\/strong>
L\u2019amylose\u00a0AA<\/span>\u00a0chez les\u00a0sujets \u00e2g\u00e9s<\/strong><\/a>
Intervenant\u202f: Dr<\/sup>\u00a0Joris Galland (Paris)
Discussion\u202f: 5\u202fmin<\/p>

15. 00<\/strong>
Neuropathie et\u00a0amylose\u202f: un\u00a0diagnostic difficile<\/strong><\/a>
Intervenante\u202f: Dr<\/sup>\u00a0Chrystel Ch\u00e9raud (Cr\u00e9teil)
Discussion\u202f: 5\u202fmin<\/p>

Session 5\u00a0– Actualit\u00e9s dans les\u00a0traitements de\u00a0l\u2019amylose<\/h5>

Mod\u00e9rateurs\u202f: Pr\u00a0Damien Logeart (Paris), Dr<\/sup>\u00a0Bruno Royer (Paris)<\/p>

16. 00<\/strong>
Amylose\u00a0AL<\/span>\u202f: place des\u00a0anticorps et\u00a0des\u00a0nouvelles chimioth\u00e9rapies\u202f?<\/strong><\/a>
Intervenant\u202f: Pr\u00a0Arnaud Jaccard (Limoges)
Discussion\u202f: 5\u202fmin<\/p>

16. 25<\/strong>
Anti\u2011sens et\u00a0amylose\u00a0TTR<\/span>\u00a0neurologique\u202f: c\u2019est\u00a0parti\u202f!<\/strong><\/a>
Intervenante\u202f: Pr\u00a0Violaine Plant\u00e9-Bordeneuve (Cr\u00e9teil)
Discussion\u202f: 5\u202fmin<\/p>

16. 45<\/strong>
Stabilisateur et\u00a0amylose\u00a0TTR<\/span>\u00a0cardiaque\u202f: enfin un\u00a0traitement\u202f?<\/strong><\/a>
Intervenant\u202f: Pr\u00a0Michel Slama (Clamart)
Discussion\u202f: 5\u202fmin<\/p>

17. 05<\/strong>
Et\u00a0le\u00a0th\u00e9 vert\u2026 r\u00eave ou\u00a0r\u00e9alit\u00e9\u202f?<\/strong><\/a>
Intervenants\u202f: Pr\u00a0Thibaud Damy, Dr<\/sup>\u00a0Bernard Do\u00a0(Cr\u00e9teil)
Discussion\u202f: 5\u202fmin<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
5e<\/sup>\u00a0JOURN\u00c9E FRANCOPHONE MULTIDISCIPLINAIRE DE\u00a0L\u2019AMYLOSE<\/h5>

Pour consulter ou\u00a0t\u00e9l\u00e9charger les\u00a0pr\u00e9sentations, veuillez cliquer sur\u00a0les\u00a0titres mentionn\u00e9es en\u00a0bleu.<\/p>

Introduction<\/h5>

Association Fran\u00e7aise contre l\u2019Amylose<\/strong><\/a><\/p>

Conf\u00e9rence<\/h5>

Mod\u00e8les animaux d\u2019amyloses\u202f: int\u00e9r\u00eats, avantages, d\u00e9fauts et\u00a0contradictions
Christophe Sirac<\/strong><\/a>\u00a0(Limoges)<\/p>

Session 1\u00a0– Nouveaux visages des\u00a0amyloses en\u00a02017\u202f?<\/h5>

Mod\u00e9rateurs\u202f: Pr\u00a0Beno\u00eet Funalot (Cr\u00e9teil), Pr\u00a0Arnaud Jaccard (Limoges)<\/p>

Amyloses cardiaques s\u00e9niles \u00e0 l\u2019heure de\u00a0la\u00a0scintigraphie\u202f:
apport diagnostique, pr\u00e9valence<\/p>

Dr<\/sup>\u00a0Olivier Lairez (Toulouse)<\/p>

Amyloses\u00a0AL<\/span>\u202f: du\u00a0nouveau dans l\u2019atteinte pulmonaire<\/p>

Dr<\/sup>\u00a0Yurdagul Uzunhan<\/strong><\/a>\u00a0(Bobigny)<\/p>

Imagerie par\u00a0IRM<\/span>\u00a0des\u00a0neuropathies amylo\u00efdes \u00e0 transthyr\u00e9tine\u202f:
nouveaux aspects et\u00a0implications
Pr\u00a0J\u00e9r\u00f4me Hodel<\/strong><\/a>\u00a0(Cr\u00e9teil)<\/p>

Vers une\u00a0m\u00e9decine translationnelle des\u00a0amyloses
Pr\u00a0Christian Delamarche<\/strong><\/a>\u00a0(Rennes)<\/p>

Session 2\u00a0– Amylose\u00a0AA<\/span>, quelle atteinte d\u2019organe\u202f?<\/h5>

Mod\u00e9rateurs\u00a0: Pr\u00a0Gilles Grateau (Paris), Dr<\/sup>\u00a0Estelle Desport (Poitiers)<\/p>

Quels facteurs pronostics de\u00a0l\u2019amylose\u00a0AA<\/span>\u00a0?<\/p>

Pr\u00a0Vincent Audard<\/strong><\/a>\u00a0(Cr\u00e9teil)<\/p>

Amylose\u00a0AA<\/span>, le\u00a0c\u0153ur a\u2011t-il\u00a0\u00e9t\u00e9 oubli\u00e9\u202f?<\/p>

Dr<\/sup>\u00a0Diane Bodez<\/strong><\/a>\u00a0(Cr\u00e9teil)<\/p>

Amylose\u00a0AA<\/span>, suivre et\u00a0traiter<\/p>

Dr<\/sup>\u00a0Sophie Georgin\u2011Lavialle<\/strong><\/a>\u00a0(Paris)<\/p>

Session 3\u00a0– Recherche clinique<\/h5>

Mod\u00e9rateurs\u00a0: Dr<\/sup>\u00a0Vincent Audard (Cr\u00e9teil), Pr\u00a0Violaine Plant\u00e9-Bordeneuve (Cr\u00e9teil)<\/p>

Comment faire simplement le\u00a0diagnostic d\u2019amylose\u00a0AL<\/span>\u00a0cardiaque<\/p>

Dr<\/sup>\u00a0Martin Nicol (Paris)<\/p>

Ob\u00e9sit\u00e9 et\u00a0Amylose\u00a0AA<\/span><\/p>

Pr\u00a0Gilles Grateau<\/strong><\/a>\u00a0(Paris)<\/p>

Variabilit\u00e9 g\u00e9n\u00e9tique et\u00a0p\u00e9n\u00e9trance dans les\u00a0amyloses\u00a0TTR<\/span><\/p>

Farida Gorram (Cr\u00e9teil)<\/p>

Session 4\u00a0– Nouveaux traitements\u202f: Antisens,\u00a0ARN<\/span>\u00a0interf\u00e9rent, Anticorps, du\u00a0r\u00eave \u00e0 la\u00a0r\u00e9alit\u00e9<\/h5>

Mod\u00e9rateurs\u00a0: Pr\u00a0Michel Slama (Clamart), Pr\u00a0Bertrand Arnulf (Paris)<\/p>

Amylose \u00e0 transthyr\u00e9tine
Pr\u00a0Thibaud Damy<\/strong><\/a>\u00a0(Cr\u00e9teil),\u00a0Pr\u00a0Violaine Plant\u00e9-Bordeneuve<\/strong><\/a>\u00a0(Cr\u00e9teil)<\/p>

Amylose\u00a0AL<\/span>\u00a0<\/p>

Pr\u00a0Arnaud Jaccard (Limoges)<\/p>

Session 5\u00a0– Sympt\u00f4mes de\u00a0l\u2019amylose, que\u00a0proposer et\u00a0dire \u00e0 nos\u00a0patients\u202f?<\/h5>

Mod\u00e9rateurs\u00a0: Dr<\/sup>\u00a0Olivier Huttin (Nancy), Pr\u00a0Thibaud Damy (Cr\u00e9teil)<\/p>

Dysautonomie cardiaque et\u00a0vasculaire<\/p>

Dr<\/sup>\u00a0Vincent Algallarondo (Clamart)<\/p>

Syndrome n\u00e9phrotique
Dr<\/sup>\u00a0Estelle Desport<\/strong><\/a>\u00a0(Poitiers)<\/p>

Trouble du\u00a0transit<\/p>

Dr<\/sup>\u00a0Aur\u00e9lien Amiot (Cr\u00e9teil)<\/p>

Int\u00e9r\u00eat d\u2019un\u00a0programme d\u2019\u00e9ducation th\u00e9rapeutique multidisciplinaire<\/p>

Sandrine Dias (Cr\u00e9teil)
Julie Pompougnac (Cr\u00e9teil)<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

La JFMA : Journ\u00e9e Francophone Multidisciplinaire de l’Amylose est une journ\u00e9e pour \u00e9changer sur les nouveaut\u00e9s scientifiques, cliniques et th\u00e9rapeutiques et l’occasion privil\u00e9gi\u00e9e d\u2019\u00e9change et de discussion entre des experts et tous les acteurs des sp\u00e9cialit\u00e9s m\u00e9dicales et biologiques confront\u00e9es au diagnostic et \u00e0 la prise en charge des patients. Visionnez les replays des journ\u00e9es […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":890,"menu_order":5,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[],"tags":[],"class_list":["post-148","page","type-page","status-publish","hentry"],"yoast_head":"\nJFMA : Journ\u00e9e Francophone Multidisciplinaire de l'Amylose - R\u00e9seau Amylose<\/title>\n<meta name=\"description\" content=\"Journ\u00e9e Francophone Multidisciplinaire Amyloses Cardiaques - Consultez les programmes et visionnez les replays des \u00e9ditions des JFMA pass\u00e9es\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/reseau-amylose.org\/jesuissoignant\/documentation\/evenements-du-reseau-amylose\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"JFMA : Journ\u00e9e Francophone Multidisciplinaire de l'Amylose - R\u00e9seau Amylose\" \/>\n<meta property=\"og:description\" content=\"Journ\u00e9e Francophone Multidisciplinaire Amyloses Cardiaques - Consultez les programmes et visionnez les replays des \u00e9ditions des JFMA pass\u00e9es\" \/>\n<meta property=\"og:url\" content=\"http:\/\/reseau-amylose.org\/jesuissoignant\/documentation\/evenements-du-reseau-amylose\/\" \/>\n<meta property=\"og:site_name\" content=\"R\u00e9seau Amylose\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-29T09:38:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/reseau-amylose.org\/jesuissoignant\/wp-content\/uploads\/sites\/5\/2022\/06\/JFMA.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"11 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/reseau-amylose.org\/jesuissoignant\/documentation\/evenements-du-reseau-amylose\/\",\"url\":\"http:\/\/reseau-amylose.org\/jesuissoignant\/documentation\/evenements-du-reseau-amylose\/\",\"name\":\"JFMA : Journ\u00e9e Francophone Multidisciplinaire de l'Amylose - R\u00e9seau Amylose\",\"isPartOf\":{\"@id\":\"https:\/\/reseau-amylose.org\/jesuissoignant\/#website\"},\"primaryImageOfPage\":{\"@id\":\"http:\/\/reseau-amylose.org\/jesuissoignant\/documentation\/evenements-du-reseau-amylose\/#primaryimage\"},\"image\":{\"@id\":\"http:\/\/reseau-amylose.org\/jesuissoignant\/documentation\/evenements-du-reseau-amylose\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/reseau-amylose.org\/jesuissoignant\/wp-content\/uploads\/sites\/5\/2022\/06\/JFMA.jpg\",\"datePublished\":\"2018-12-06T00:29:26+00:00\",\"dateModified\":\"2022-06-29T09:38:10+00:00\",\"description\":\"Journ\u00e9e Francophone Multidisciplinaire Amyloses Cardiaques - Consultez les programmes et visionnez les replays des \u00e9ditions des JFMA pass\u00e9es\",\"breadcrumb\":{\"@id\":\"http:\/\/reseau-amylose.org\/jesuissoignant\/documentation\/evenements-du-reseau-amylose\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/reseau-amylose.org\/jesuissoignant\/documentation\/evenements-du-reseau-amylose\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"http:\/\/reseau-amylose.org\/jesuissoignant\/documentation\/evenements-du-reseau-amylose\/#primaryimage\",\"url\":\"http:\/\/reseau-amylose.org\/jesuissoignant\/wp-content\/uploads\/sites\/5\/2022\/06\/JFMA.jpg\",\"contentUrl\":\"http:\/\/reseau-amylose.org\/jesuissoignant\/wp-content\/uploads\/sites\/5\/2022\/06\/JFMA.jpg\",\"width\":426,\"height\":306},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/reseau-amylose.org\/jesuissoignant\/documentation\/evenements-du-reseau-amylose\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/reseau-amylose.org\/jesuissoignant\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Documentation\",\"item\":\"https:\/\/reseau-amylose.org\/jesuissoignant\/documentation\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"JFMA : Journ\u00e9e Francophone Multidisciplinaire de l’Amylose\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/reseau-amylose.org\/jesuissoignant\/#website\",\"url\":\"https:\/\/reseau-amylose.org\/jesuissoignant\/\",\"name\":\"R\u00e9seau Amylose\",\"description\":\"Centre de r\u00e9f\u00e9rence des amyloses cardiaques espace soignant\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/reseau-amylose.org\/jesuissoignant\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"JFMA : Journ\u00e9e Francophone Multidisciplinaire de l'Amylose - R\u00e9seau Amylose","description":"Journ\u00e9e Francophone Multidisciplinaire Amyloses Cardiaques - Consultez les programmes et visionnez les replays des \u00e9ditions des JFMA pass\u00e9es","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/reseau-amylose.org\/jesuissoignant\/documentation\/evenements-du-reseau-amylose\/","og_locale":"fr_FR","og_type":"article","og_title":"JFMA : Journ\u00e9e Francophone Multidisciplinaire de l'Amylose - R\u00e9seau Amylose","og_description":"Journ\u00e9e Francophone Multidisciplinaire Amyloses Cardiaques - Consultez les programmes et visionnez les replays des \u00e9ditions des JFMA pass\u00e9es","og_url":"http:\/\/reseau-amylose.org\/jesuissoignant\/documentation\/evenements-du-reseau-amylose\/","og_site_name":"R\u00e9seau Amylose","article_modified_time":"2022-06-29T09:38:10+00:00","og_image":[{"url":"https:\/\/reseau-amylose.org\/jesuissoignant\/wp-content\/uploads\/sites\/5\/2022\/06\/JFMA.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"11 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/reseau-amylose.org\/jesuissoignant\/documentation\/evenements-du-reseau-amylose\/","url":"http:\/\/reseau-amylose.org\/jesuissoignant\/documentation\/evenements-du-reseau-amylose\/","name":"JFMA : Journ\u00e9e Francophone Multidisciplinaire de l'Amylose - R\u00e9seau Amylose","isPartOf":{"@id":"https:\/\/reseau-amylose.org\/jesuissoignant\/#website"},"primaryImageOfPage":{"@id":"http:\/\/reseau-amylose.org\/jesuissoignant\/documentation\/evenements-du-reseau-amylose\/#primaryimage"},"image":{"@id":"http:\/\/reseau-amylose.org\/jesuissoignant\/documentation\/evenements-du-reseau-amylose\/#primaryimage"},"thumbnailUrl":"https:\/\/reseau-amylose.org\/jesuissoignant\/wp-content\/uploads\/sites\/5\/2022\/06\/JFMA.jpg","datePublished":"2018-12-06T00:29:26+00:00","dateModified":"2022-06-29T09:38:10+00:00","description":"Journ\u00e9e Francophone Multidisciplinaire Amyloses Cardiaques - Consultez les programmes et visionnez les replays des \u00e9ditions des JFMA pass\u00e9es","breadcrumb":{"@id":"http:\/\/reseau-amylose.org\/jesuissoignant\/documentation\/evenements-du-reseau-amylose\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["http:\/\/reseau-amylose.org\/jesuissoignant\/documentation\/evenements-du-reseau-amylose\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"http:\/\/reseau-amylose.org\/jesuissoignant\/documentation\/evenements-du-reseau-amylose\/#primaryimage","url":"http:\/\/reseau-amylose.org\/jesuissoignant\/wp-content\/uploads\/sites\/5\/2022\/06\/JFMA.jpg","contentUrl":"http:\/\/reseau-amylose.org\/jesuissoignant\/wp-content\/uploads\/sites\/5\/2022\/06\/JFMA.jpg","width":426,"height":306},{"@type":"BreadcrumbList","@id":"http:\/\/reseau-amylose.org\/jesuissoignant\/documentation\/evenements-du-reseau-amylose\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/reseau-amylose.org\/jesuissoignant\/"},{"@type":"ListItem","position":2,"name":"Documentation","item":"https:\/\/reseau-amylose.org\/jesuissoignant\/documentation\/"},{"@type":"ListItem","position":3,"name":"JFMA : Journ\u00e9e Francophone Multidisciplinaire de l’Amylose"}]},{"@type":"WebSite","@id":"https:\/\/reseau-amylose.org\/jesuissoignant\/#website","url":"https:\/\/reseau-amylose.org\/jesuissoignant\/","name":"R\u00e9seau Amylose","description":"Centre de r\u00e9f\u00e9rence des amyloses cardiaques espace soignant","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/reseau-amylose.org\/jesuissoignant\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"http:\/\/reseau-amylose.org\/jesuissoignant\/wp-json\/wp\/v2\/pages\/148","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/reseau-amylose.org\/jesuissoignant\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/reseau-amylose.org\/jesuissoignant\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/reseau-amylose.org\/jesuissoignant\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/reseau-amylose.org\/jesuissoignant\/wp-json\/wp\/v2\/comments?post=148"}],"version-history":[{"count":124,"href":"http:\/\/reseau-amylose.org\/jesuissoignant\/wp-json\/wp\/v2\/pages\/148\/revisions"}],"predecessor-version":[{"id":5452,"href":"http:\/\/reseau-amylose.org\/jesuissoignant\/wp-json\/wp\/v2\/pages\/148\/revisions\/5452"}],"up":[{"embeddable":true,"href":"http:\/\/reseau-amylose.org\/jesuissoignant\/wp-json\/wp\/v2\/pages\/890"}],"wp:attachment":[{"href":"http:\/\/reseau-amylose.org\/jesuissoignant\/wp-json\/wp\/v2\/media?parent=148"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/reseau-amylose.org\/jesuissoignant\/wp-json\/wp\/v2\/categories?post=148"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/reseau-amylose.org\/jesuissoignant\/wp-json\/wp\/v2\/tags?post=148"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}